Филграстим се използва като съставка на други лекарства в Европейския съюз (ЕС) от много години.
The filgrastim in Neulasta is produced by a method known as ‘ recombinant DNA technology’: it is made by a bacterium that has received a gene (DNA), which makes it able to produce filgrastim.